HR 4626
118th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Family planning and birth control
Government information and archives
Government studies and investigations
Prescription drugs
Women's health
OTC Act of 2023
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 14, 2023
Referred to the Subcommittee on Health.
Jul 13, 2023
Introduced in House
Jul 13, 2023
Referred to the House Committee on Energy and Commerce.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Orally Taken Contraception Act of 2023 or the OTC Act of 2023
This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 4626: OTC Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4626/
"H.R. 4626: OTC Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4626/.
H.R. 4626, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4626/.
[H.R. 4626: OTC Act of 2023](https://openamerica.io/bill/118-HR-4626/)